Market Research Logo

ImmunoGen, Inc - Strategy and SWOT Report

ImmunoGen, Inc - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on ImmunoGen, Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting ImmunoGen, Inc in the form of a SWOT analysis
  • An in-depth view of the business model of ImmunoGen, Inc including a breakdown and examination of key business segments
  • Intelligence on ImmunoGen, Inc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about ImmunoGen, Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

ImmunoGen (or ‘the company’) is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology comprises the company’s portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. ImmunoGen is headquartered in Waltham, Massachusetts, and employed 280 people as of June 30, 2013. The company recorded revenues of $35.5 million during the financial year ended June 2013 (FY2013), as compared to the revenues of $16.4 million in FY2012. The operating loss of the company was $73 million in FY2013, as compared to an operating loss of $73.3 million in FY2012. The net loss was $72.8 million in FY2013, as compared to a net loss of $73.3 million in FY2012.

Reasons to Purchase:
  • Gain understanding of ImmunoGen, Inc and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess ImmunoGen, Inc as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on ImmunoGen, Inc’s business structure, strategy and prospects


Company Snapshot
ImmunoGen, Inc: Company Overview
ImmunoGen, Inc: Overview and Key Facts
ImmunoGen, Inc: Overview
ImmunoGen, Inc: Key Facts
ImmunoGen, Inc: Key Employees
ImmunoGen, Inc: Key Employee Biographies
ImmunoGen, Inc: Major Products and Services
ImmunoGen, Inc: Company History
ImmunoGen, Inc: Management Statement
ImmunoGen, Inc: Locations and Subsidiaries
ImmunoGen, Inc: Key Competitors
ImmunoGen, Inc: Company Analysis
ImmunoGen, Inc: Business Description
ImmunoGen, Inc: SWOT Analysis
ImmunoGen, Inc: SWOT Overview
ImmunoGen, Inc: Strengths
ImmunoGen, Inc: Weaknesses
ImmunoGen, Inc: Opportunities
ImmunoGen, Inc: Threats
ImmunoGen, Inc: Corporate Financial Deals Activity
ImmunoGen, Inc: Financial Deals Overview
ImmunoGen, Inc: Targets and Partners
ImmunoGen, Inc: Top Deals 2011 - 2015YTD*
ImmunoGen, Inc: Advisors
ImmunoGen, Inc: Top Legal Advisors
ImmunoGen, Inc: Top Financial Advisors
ImmunoGen, Inc: Capital Raising
ImmunoGen, Inc: Partnership
ImmunoGen, Inc: Recent Developments
ImmunoGen, Inc: News and Events Summary
ImmunoGen, Inc: Contracts
ImmunoGen, Inc: Corporate Governance
ImmunoGen, Inc: Financial Deals
ImmunoGen, Inc: Financial Performance
ImmunoGen, Inc: Regulatory and Legal Events
ImmunoGen, Inc: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor
List of Tables
Table 1: ImmunoGen, Inc: Key Facts
Table 2: ImmunoGen, Inc: Key Employees
Table 4: ImmunoGen, Inc: Key Competitors
Table 5: ImmunoGen, Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: ImmunoGen, Inc: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Table 7: ImmunoGen, Inc: Targets and Partners
Table 8: ImmunoGen, Inc: Top Deals 2011 - 2015YTD*
Table 9: ImmunoGen, Inc: Legal Advisor Ranking by Value (US$m)
Table 10: ImmunoGen, Inc: Financial Advisor Ranking by Value (US$m)
Table 11: ImmunoGen, Inc: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Table 12: ImmunoGen, Inc: Capital Raising by Deal Type (2011 - YTD*2015)
Table 13: ImmunoGen, Inc: Partnership Volume and Value Trend (2011 - YTD*2015)
Table 14: ImmunoGen, Inc: Partnership Trend by Deal Type (2011 - YTD*2015)
Table 15: ImmunoGen, Inc: News and Events Summary
Table 16: ImmunoGen, Inc: Contracts
Table 17: ImmunoGen, Inc: Corporate Governance
Table 18: ImmunoGen, Inc: Financial Deals
Table 19: ImmunoGen, Inc: Financial Performance
Table 20: ImmunoGen, Inc: Regulatory and Legal Events
Table 21: ImmunoGen, Inc: Research & Development
List of Figures
Figure 1: ImmunoGen, Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: ImmunoGen, Inc: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
Figure 3: ImmunoGen, Inc: Capital Raising Volume and Value Trend (2011 - YTD*2015)
Figure 4: ImmunoGen, Inc: Capital Raising by Deal Type (2011 - YTD*2015)
Figure 5: ImmunoGen, Inc: Partnership Volume and Value Trend (2011 - YTD*2015)
Figure 6: ImmunoGen, Inc: Partnership Trend by Deal Type (2011 - YTD*2015)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report